Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety and the pharmacokinetic characteristics of
docetaxel between two docetaxel products in patients with advanced solid cancer.